Ángela Santonja

571 total citations
11 papers, 99 citations indexed

About

Ángela Santonja is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Ángela Santonja has authored 11 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ángela Santonja's work include Cancer Genomics and Diagnostics (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Ángela Santonja is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Ángela Santonja collaborates with scholars based in Spain, United States and South Korea. Ángela Santonja's co-authors include Emilio Alba, Nuria Ribelles, Casilda Llácer, Bella Pajares, Alfonso Sánchez‐Muñoz, Soomin Ahn, Carlos Caldas, Federico Rojo, Helen Bardwell and Mae A. Goldgraben and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Ángela Santonja

8 papers receiving 99 citations

Peers

Ángela Santonja

ONCOL

GENET

PHEOH

Kelsey Finn United States

Valentina A. Zavala United States

F Marmé Germany

D-M. Zahm Germany

Adam J. Widman United States

Kenneth Eng United States

Nicholas Ang United States

Venkata D. Yellapantula United States

Jeremy S. Gresham United States

K. Knox United Kingdom

Kelsey Finn United States

Ángela Santonja

20 ×0.5

34 ×0.9

33 ×1.1

ONCOL

17 ×0.7

GENET

4 ×0.2

PHEOH

Citations per year, relative to Ángela Santonja Ángela Santonja (= 1×) peers Kelsey Finn

Countries citing papers authored by Ángela Santonja

Since Specialization

Citations

This map shows the geographic impact of Ángela Santonja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Santonja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Santonja more than expected).

Fields of papers citing papers by Ángela Santonja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Santonja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Santonja. The network helps show where Ángela Santonja may publish in the future.

Co-authorship network of co-authors of Ángela Santonja

This figure shows the co-authorship network connecting the top 25 collaborators of Ángela Santonja. A scholar is included among the top collaborators of Ángela Santonja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángela Santonja. Ángela Santonja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Santonja, Ángela, Aurelio A. Moya‐García, Nuria Ribelles, et al.. (2022). Role of germline variants in the metastasis of breast carcinomas. Oncotarget. 13(1). 843–862. 2 indexed citations

Chin, Suet‐Feung, Ángela Santonja, Marta Grzelak, et al.. (2018). Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers. Experimental and Molecular Pathology. 104(3). 161–169. 23 indexed citations

Sánchez‐Muñoz, Alfonso, Luís Vicioso, Ángela Santonja, et al.. (2017). Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes. Modern Pathology. 31(2). 299–306. 18 indexed citations

Berciano‐Guerrero, Miguel‐Ángel, Rocío Lavado-Valenzuela, A. Montesa, et al.. (2017). Different patterns of non immediate allergic reaction to BRAF inhibitor in two patients with metastatic melanoma.. Journal of Clinical Oncology. 35(15_suppl). e21052–e21052.

Santonja, Ángela, Joan Albanell, Alfonso Sánchez‐Muñoz, et al.. (2016). Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer. Annals of Oncology. 27. vi55–vi55.

Santonja, Ángela, Bella Pajares, Nuria Ribelles, et al.. (2016). Germline genetic background contribution to metastatic dissemination in breast cancer extreme phenotype patients. Annals of Oncology. 27. vi546–vi546. 1 indexed citations

Santonja, Ángela, Alfonso Sánchez‐Muñoz, Vanessa de Luque, et al.. (2016). Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes.. Journal of Clinical Oncology. 34(15_suppl). 1585–1585.

Santonja, Ángela, Nuria Ribelles, Pedro Sánchez‐Rovira, et al.. (2016). Abstract P3-07-14: Prosigna® intrinsic subtyping predicts response to neoadjuvant combination therapy in study that includes herceptin within HER2+ (IHC) patients. Cancer Research. 76(4_Supplement). P3–7. 1 indexed citations

Sánchez‐Muñoz, Alfonso, et al.. (2015). Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer. Clinical Breast Cancer. 15(5). 343–347. 10 indexed citations

10.

Santonja, Ángela, Joan Albanell, José Ignacio Chacón, et al.. (2014). Triple-negative breast cancer subtypes and pathologic complete-response rate to neoadjuvant chemotherapy: Results from the GEICAM/2006-2003 study.. Journal of Clinical Oncology. 32(15_suppl). 1024–1024. 1 indexed citations

11.

Ribelles, Nuria, Ángela Santonja, Bella Pajares, Casilda Llácer, & Emilio Alba. (2013). The seed and soil hypothesis revisited: Current state of knowledge of inherited genes on prognosis in breast cancer. Cancer Treatment Reviews. 40(2). 293–299. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact